As of 2026-03-29, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (47.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -284.8%.
The range of the Relative Valuation is (43.51) - (50.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 25.1x | 22.0x |
| Forward P/E multiples | 19.8x - 22.9x | 21.0x |
| Fair Price | (43.51) - (50.42) | (47.28) |
| Upside | -270.0% - -297.0% | -284.8% |
| Date | P/E |